Collegium Pharmaceutical Earnings Loss from Eq. Investments (TTM) Analysis

Collegium Pharmaceutical, Inc. (COLL)

45.50 -1.60 (-3.40%) USD | NASDAQ | Jan 23, 16:00

45.52 +0.02 (+0.04%) Pre-Market: 20:00

View Earnings Loss from Eq. Investments (TTM) for COLL.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Earnings Loss from Eq. Investments (TTM) Chart

Start Trial

View Historical Data

Start Trial

View Earnings Loss from Eq. Investments (TTM) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Earnings Loss from Eq. Investments (TTM) Benchmarks

Start Trial

Catalyst Pharmaceuticals, Inc.	--
Intuitive Surgical, Inc.	--
Hims & Hers Health, Inc.	--
Alnylam Pharmaceuticals, Inc.	--
Corcept Therapeutics, Inc.	--